Dasatinib 100 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FLYJN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,261
Award facts
- Contract value 100% obligated
- $8,260.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,260.56 to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count units) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Dasatinib is a tyrosine kinase inhibitor used in the treatment of certain leukemias and other cancers, reflecting the Defense Logistics Agency's medical supply chain requirements for oncology pharmaceuticals supporting military and veteran healthcare systems.
This delivery order represents a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp leverages this comprehensive prime vendor vehicle to supply a wide range of pharmaceutical products, specialty medications, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The company's continued selection for such awards demonstrates its capability to meet federal procurement standards and fulfill specialized pharmaceutical requirements through open competition.
Quick answers
Who was awarded contract SPE2DB25FLYJN?
SPE2DB25FLYJN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FLYJN worth?
The government has obligated $8,261 on SPE2DB25FLYJN.
Is contract SPE2DB25FLYJN an order under another contract?
Yes. SPE2DB25FLYJN is a delivery order under SPE2DB20D6035, an indefinite delivery contract.
Was contract SPE2DB25FLYJN competed?
The extent of competition for SPE2DB25FLYJN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award